NCT02497313View on ClinicalTrials.gov

Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Isotonic saline

DRUG

Metformin placebo

DRUG

Cholecystokinin

DRUG

Metformin

Trial Locations (1)

2900

Center for Diabetes Research, Herlev-Gentofte Hospital, Hellerup

All Listed Sponsors

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT02497313 - Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes | Biotech Hunter | Biotech Hunter